In this regard, paying more attention to purinergic signaling in the SG is expected to help understand the comprehensive mechanisms and develop a novel therapeutic approach for targeting purinergic receptors in DM patients to restore or relieve SG-related complications, such as SG infection control and saliva flow promotion13. The gene discussed is P2RX7; the disease is diabetes mellitus.